Homogentisate 1,2-Dioxygenase (HGD) Peptid
Kurzübersicht für Homogentisate 1,2-Dioxygenase (HGD) Peptid (ABIN939893)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- KLFAAKQDVS PFNVVAWHGN YTPYKYNLKN FMVINSVAFD HADPSIFTVL
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of HGD antibody,
Alternative Names: HGD control peptide, HGD antibody Blocking Peptide, Anti-HGD Blocking Peptide, Homogentisate 12-Dioxygenase Blocking Peptide, Homogentisate Oxidase Blocking Peptide, AKU Blocking Peptide, HGO Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- HGD (Homogentisate 1,2-Dioxygenase (HGD))
-
Hintergrund
- Homogentisate 1,2-dioxygenase (HGD) gene mutations are the molecular cause of alkaptonuria, a rare hereditary disorder of the phenylalanine catabolism. The highest expression of HGD is in the prostate, small intestine, colon, and liver.
-
Molekulargewicht
- 50 kDa
Target
-